In summary, AT inflammation is the key initiating factor driving lipid metabolism disorders, specifically dyslipidemia, and glucose metabolism imbalance, including insulin resistance, hyperglycemia, and AGEs accumulation. The gene discussed is INS; the disease is Hyperglycemia.